Online Newsroom
 Thomas
DiPetrillo, MD
Thomas DiPetrillo, MD, is clinical director of radiation oncology
at Rhode Island Hospital. He is a leading authority on a variety
of radiation treatments for cancer, including intensity
modulated radiation therapy (IMRT) and high
dose rate (HDR) brachytherapy.
DiPetrillo is a pioneer in the use of IMRT, a non-invasive procedure
that allows physicians to pinpoint delivery of radiation therapy,
resulting in better tumor control with less toxicity. He is also
an expert in the use of HDR brachytherapy, a treatment that involves
the use of a robotic arm to deliver a radioactive "seed"
to a tumor. HDR brachytherapy is considered a versatile option in
the treatment of cancer, as it can be used for almost any cancer
at any stage, with patients treated on an outpatient basis. In 2003,
DiPetrillo combined the use of HDR brachytherapy with another treatment,
radiofrequency ablation, to treat a recurrent lung cancer in a 70-year-old
man. This combination treatment is now being studied in a national
multi-site trial led by Rhode Island Hospital.
DiPetrillo is also an associate professor at Brown Medical School
in Providence, RI, and an adjunct assistant professor at Tufts University
School of Medicine in Boston. He has served on national committees
and research groups, including the National Cancer Institute/Intensity
Modulated Radiation Therapy (IMRT) Guidelines Committee; the American
College of Surgeons Oncology Group Thoracic Subcommittee; Cancer
and Lymphoma Group B; and Radiation Therapy Oncology Group.
More
about radiation oncology
|
